Alluvi Retatrutide and the Future of Triple-Action Metabolic Research

Understanding Alluvi Retatrutide Alluvi retatrutide is a term associated with retatrutide products promoted for research purposes by Alluvi Healthcare. Retatrutide itself is an investigational compound developed by Eli Lilly that works differently from many existing weight-management medicines because it activates three hormone receptors: GIP, GLP-1, and glucagon. This triple-action mechanism has attracted considerable attention in…